CHELSEA NELSON: Open Payments
NPI 1992054126 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 25 payments from 7 companies in 2025. Trend: 2023 $885 · 2024 $1,222 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $233 |
| Gilead Sciences, Inc. | 5 | $119 |
| PFIZER INC. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: RINVOQ, SKYRIZI, MAVYRET, EOHILIA, XELJANZ, ZENPEP, VELSIPITY, IBSRELA.
Industry payments across CO — which companies pay providers there.
